跳至主要内容
临床试验/CTRI/2018/03/012710
CTRI/2018/03/012710尚未招募2 期

A Prospective Open Labelled Non Randomized Clinical Trial on herbal formulation of NERUNJI VER KUDINEER for the treatment of KALLADAIPPU[Urolithiasis]

Dr S Neelavathi MD PhD1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2018年3月4日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Therapeutic efficacy of taial drug NERUNJI VER KUDINEER in KALLADAIPPU

研究概览

简要总结

The study is A Prospective Open Labelled   Non Randomized clinical study to evaluate the therapeutic efficacy of NERUNJI VER KUDINEER 100ml BD for30 days in 40 patients during the trial period of 15 months that will be conducted in Govt Siddha Medical College and Hospital Palayamkottai Tirunelveli Tamilnadu The primary outcome will be the therapeutic efficacy of trial drug NERUNJI VER KUDINEER in KALLADAIPPU The secondry outcome will be the evaluation of Siddha diagnostic parameters safety of trial drug Pharmacological and Biochemical analysis of trial drug

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
30.00 Day(s) 至 60.00 Day(s)(—)
性别
All

入选标准

  • Age from 30 years to 60 years Patient With Renal Colicky pain Nausea Vomiting Haematuria Oliguria Pyuria Dysuria.

排除标准

  • Age Below 30 years and above 60 years Chronic Appendicitis Cholecystitis Pyelonephritis Recurrent UTI Diabetes Mellitus Metabolic disorders like Hyperthyroidism Hyperparathyroidism Pelvic Inflammatory Disease Chronic Renal Failure.

结局指标

主要结局

Therapeutic efficacy of taial drug NERUNJI VER KUDINEER in KALLADAIPPU

时间窗: 30 days

次要结局

  • Evaluation of Sidhha diagnostic parameters safety of trial drug Pharmacological and Biochemical analysis of trial drug(30 days)

研究者

发起方
Dr S Neelavathi MD PhD
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验

A clinical study NERUNJI VER KUDINEER for... | 临床试验